| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |